Clinical trials recruiting in Plainfield, Indiana

Phase breakdown

Conditions recruiting in Plainfield, Indiana

Recruiting trials in Plainfield, Indiana

• A 3-part Study of SYX-5219 in Healthy Volunteers and Participants With Atopic Dermatitis
  NCT07558668 · Phase: Phase 1 · Ages: 18 Years to 65 Years · Sex: All (male and female)
• A Phase 2b Dose-Ranging Study to Evaluate the Efficacy and Safety of ENV-294 in Adults With Moderate-to-Severe Atopic Dermatitis
  NCT07643766 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female)
• A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)
  NCT06857942 · Phase: Phase 4 · Ages: 18 Years and older · Sex: All (male and female)
• Ph 1a/1b Single Ascending Dose and Multiple Ascending Dose Study of ARQ-234
  NCT07453602 · Phase: Phase 1 · Ages: 18 Years to 65 Years · Sex: All (male and female)

Common questions

How many clinical trials are recruiting in Plainfield, Indiana?

4 recruiting trials have at least one study site in Plainfield, Indiana.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.